Cartesian Therapeutics
RNAC
#8958
Rank
โ‚ฌ0.17 B
Marketcap
5,60ย โ‚ฌ
Share price
4.24%
Change (1 day)
-10.96%
Change (1 year)

EPS for Cartesian Therapeutics (RNAC)

EPS in 2026 (TTM): -1,59ย โ‚ฌ

According to Cartesian Therapeutics's latest financial reports the company's current EPS (TTM) is -1,70ย โ‚ฌ. In 2021 the company made an earnings per share (EPS) of -6,56ย โ‚ฌ an increase over its 2020 EPS that were of -18,87ย โ‚ฌ.

EPS history for Cartesian Therapeutics from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-1,59ย โ‚ฌ
2021-6,56ย โ‚ฌ-65.22%
2020-18,87ย โ‚ฌ-43.44%
2019-33,36ย โ‚ฌ-58.08%
2018-79,58ย โ‚ฌ-9.35%
2017-87,79ย โ‚ฌ-29.16%
2016-123,92ย โ‚ฌ